Rezular – Oral Treatment for IBS

AGI Therapeutics is developing a range of drugs to treat a variety of common GI diseases and disorders, including IBS, functional dyspepsia, ulcerative colitis and gastro-esophageal reflux disease (GERD).


«Back

Return to Project